🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
43Score
DipBuster Score™
$405.00
$4.2 (0%)
Live price · Source: FMP-live
52-Week Position
$353.99
25% of range
$556.52
Beta
1.109
Market-like
Dividend
—
no income
Mkt Cap
$87.68B
total value
Mkt Cap$87.68B
P/EN/A
DividendNone
Beta1.109
52W High$556.52
52W Low$353.99
DipBuster Brief
Key signals at a glance
Zone: Buy Zone
Bullish
Near 52-Week Low — Wide Margin of Safety
At 25% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt Cap$87.68B
52W Position25% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta1.109
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at HCA Healthcare, Inc. (HCA), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-26 | Mcalevey Michael R | SELL | 7,769 |
| 2026-05-07 | Marks Mike A | BUY | 3,336 |
| 2026-05-07 | Marks Mike A | SELL | 3,336 |
| 2026-04-28 | Smith Andrea B | BUY | 509 |
| 2026-04-28 | Frist William R | BUY | 809 |
| 2026-04-28 | Riley Wayne Joseph | BUY | 509 |
| 2026-04-28 | Johnston Hugh F | BUY | 809 |
| 2026-04-28 | Frist Thomas F Iii | BUY | 1,041 |
| 2026-04-28 | Michelson Michael W | BUY | 925 |
| 2026-04-28 | Deparle Nancy Ann | BUY | 509 |
Valuation
P/E RatioN/A
Market Cap$87.68B
Beta1.109
Dividend/yrNone
52W High$556.52
52W Low$353.99
52-Week Range
$353.99Now$556.52
25% through annual range
From 52W High−27.2%
From 52W Low+14.4%
📖 Plain English Summary
HCA Healthcare, Inc. is at 25% of its 52-week range. Beta 1.109 — moves broadly in line with the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for HCA
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — HCA
Heuristic · balance sheet, insider filings, price data, academic research
HCA Healthcare, Inc. — DipBuster Score 43/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track HCA Healthcare, Inc. free
Add HCA to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
30/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
22
/100 · NEUTRAL
dip depth
11/25
oversold rsi
4/25
mean reversion
8/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 43/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that pr…
Sector
Healthcare
Market
🇺🇸 US
CEO
Samuel N. Hazen
Staff
320,000 employees
Website